Craft
  • Home
  •  / ARIAD Pharmaceuticals
ARIAD Pharmaceuticals

ARIAD Pharmaceuticals

Revenue

$118.8 M

FY, 2015

ARIAD Pharmaceuticals Summary

Company summary

Overview
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. It is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. The Company utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.
Type
Subsidiary
Founded
1991
HQ
Cambridge, MA, US | view all locations
Website
http://www.ariad.com
Cybersecurity rating
Sectors

LocationsView all

13 locations detected

  • Cambridge, MA HQ

    United States

    40 Landsdowne St

  • Boston, MA

    United States

    Boston, MA, USA

  • Chicago, IL

    United States

    Chicago, IL, USA

  • Cincinnati, OH

    United States

    Cincinnati, OH, USA

  • Dallas, TX

    United States

    Dallas, TX, USA

  • Minneapolis, MN

    United States

    Minneapolis, MN, USA

and 7 others

ARIAD Pharmaceuticals Financials

Summary financials

Revenue (Q3, 2016)
$46.0M
Gross profit (Q3, 2016)
$44.9M
Net income (Q3, 2016)
($27.8M)
Cash (Q3, 2016)
$305.0M
EBIT (Q3, 2016)
($25.0M)

Footer menu